Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 548-560

  Sanz García, Marta ^a   Vázquez Cedeira, Marta ^a   Kellerman, Efrat ^b   Renbaum, Paul ^b   Levy Lahad, Ephrat ^b   Lazo, Pedro A ^a  

^a Salamanca Spain   (Spain)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Ataxia; Coilin; Neurodegeneration; SMA; VRK1; VRK2

Indexed keywords

COILIN; NUCLEAR PROTEIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VACCINIA RELATED KINASE 1; VACCINIA RELATED KINASE 2;

AMINO ACID SEQUENCE; ARTICLE; ATAXIA; COILED BODY; CONTROLLED STUDY; CYTOSOL; ENZYME SUBSTRATE; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY;

HEK293 CELLS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SUBSTRATE SPECIFICITY; TRANSFECTION; VACCINIA VIRUS;

EID: 82355180990     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.08.019     Document Type: Article

References (60)

1. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
2. Zhang J., Yang P.L., Gray N.S. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009, 9:28-39.
3. Kreegipuu A., Blom N., Brunak S., Jarv J. Statistical analysis of protein kinase specificity determinants. FEBS Lett 1998, 430:45-50.
4. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999, 294:1351-1362.
5. Saunders N.F., Brinkworth R.I., Huber T., Kemp B.E., Kobe B. Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites. BMC Bioinformatics 2008, 9:245.
6. Brinkworth R.I., Breinl R.A., Kobe B. Structural basis and prediction of substrate specificity in protein serine/threonine kinases. Proc Natl Acad Sci USA 2003, 100:74-79.
7. Songyang Z., Blechner S., Hoagland N., Hoekstra M.F., Piwnica-Worms H., Cantley L.C. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 1994, 4:973-982.
8. Vega F.M., Sevilla A., Lazo P.A. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol Cell Biol 2004, 24:10366-10380.
9. Neumann B., Walter T., Heriche J.K., Bulkescher J., Erfle H., Conrad C., et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010, 464:721-727.
10. Valbuena A., Sanz-Garcia M., Lopez-Sanchez I., Vega F.M., Lazo P.A. Roles of VRK1 as a new player in the control of biological processes required for cell division. Cell Signal 2011, 23:1267-1272.
11. Nichols R.J., Traktman P. Characterization of three paralogous members of the mammalian vaccinia related kinase family. J Biol Chem 2004, 279:7934-7946.
12. Scheeff E.D., Eswaran J., Bunkoczi G., Knapp S., Manning G. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 2009, 17:128-138.
13. Lopez-Borges S., Lazo P.A. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 2000, 19:3656-3664.
14. Blanco S., Klimcakova L., Vega F.M., Lazo P.A. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines. FEBS J 2006, 273:2487-2504.
15. Sanz-Garcia M., Lopez-Sanchez I., Lazo P.A. Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities. Mol Cell Proteomics 2008, 7:2199-2214.
16. Good M.C., Zalatan J.G., Lim W.A. Scaffold proteins: hubs for controlling the flow of cellular information. Science 2011, 332:680-686.
17. Diella F., Cameron S., Gemund C., Linding R., Via A., Kuster B., et al. Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics 2004, 5:79.
18. Diella F., Gould C.M., Chica C., Via A., Gibson T.J. Phospho.ELM: a database of phosphorylation sites-update 2008. Nucleic Acids Res 2008, 36:D240-D244.
19. Diks S.H., Kok K., O'Toole T., Hommes D.W., van Dijken P., Joore J., et al. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J Biol Chem 2004, 279:49206-49213.
20. Amanchy R., Zhong J., Molina H., Chaerkady R., Iwahori A., Kalume D.E., et al. Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays. J Proteome Res 2008, 7:3900-3910.
21. Wang H., Brautigan D.L. Peptide microarray analysis of substrate specificity of the transmembrane Ser/Thr kinase KPI-2 reveals reactivity with cystic fibrosis transmembrane conductance regulator and phosphorylase. Mol Cell Proteomics 2006, 5:2124-2130.
22. Parikh K., Diks S.H., Tuynman J.H., Verhaar A., Lowenberg M., Hommes D.W., et al. Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8. PLoS One 2009, 4:e6440.
23. Lowenberg M., Tuynman J., Bilderbeek J., Gaber T., Buttgereit F., van Deventer S., et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 2005, 106:1703-1710.
24. Barcia R., Lopez-Borges S., Vega F.M., Lazo P.A. Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. Arch Biochem Biophys 2002, 399:1-5.
25. Sevilla A., Santos C.R., Barcia R., Vega F.M., Lazo P.A. c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 2004, 23:8950-8958.
26. Valbuena A., Lopez-Sanchez I., Lazo P.A. Human VRK1 is an early response gene and its loss causes a block in cell cycle progression. PLoS One 2008, 3:e1642.
27. Valbuena A., Vega F.M., Blanco S., Lazo P.A. p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop. Mol Cell Biol 2006, 26:4782-4793.
28. Valbuena A., Castro-Obregon S., Lazo P.A. Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway. PLoS One 2011, 6:e17320.
29. Blanco S., Sanz-Garcia M., Santos C.R., Lazo P.A. Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein. PLoS One 2008, 3:e1660.
30. Blanco S., Santos C., Lazo P.A. Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1. Mol Cell Biol 2007, 27:7273-7283.
31. Fernandez I.F., Blanco S., Lozano J., Lazo P.A. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer. Mol Cell Biol 2010, 30:4687-4697.
32. Toyota C.G., Davis M.D., Cosman A.M., Hebert M.D. Coilin phosphorylation mediates interaction with SMN and SmB'. Chromosoma 2010, 119:205-215.
33. Hong S., Ka S., Kim S., Park Y., Kang S. p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product. Biochim Biophys Acta 2003, 1638:35-42.
34. Renbaum P., Kellerman E., Jaron R., Geiger D., Segel R., Lee M., et al. Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. Am J Hum Genet 2009, 85:281-289.
35. Valbuena A., Lopez-Sanchez I., Vega F.M., Sevilla A., Sanz-Garcia M., Blanco S., et al. Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. Arch Biochem Biophys 2007, 465:219-226.
36. Sevilla A., Santos C.R., Vega F.M., Lazo P.A. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J Biol Chem 2004, 279:27458-27465.
37. Tuynman J.B., Vermeulen L., Boon E.M., Kemper K., Zwinderman A.H., Peppelenbosch M.P., et al. Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res 2008, 68:1213-1220.
38. Shin J., Chakraborty G., Bharatham N., Kang C., Tochio N., Koshiba S., et al. NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity. J Biol Chem 2011, 286:22131-22138.
39. Vazquez-Cedeira M., Barcia-Sanjurjo I., Sanz-Garcia M., Barcia R., Lazo P.A. Differential inhibitor sensitivity between human kinases VRK1 and VRK2. PLoS One 2011, 6:e23235.
40. Kang T.H., Park D.Y., Choi Y.H., Kim K.J., Yoon H.S., Kim K.T. Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol Cell Biol 2007, 27:8533-8546.
41. Hebert M.D., Matera A.G. Self-association of coilin reveals a common theme in nuclear body localization. Mol Biol Cell 2000, 11:4159-4171.
42. Shpargel K.B., Ospina J.K., Tucker K.E., Matera A.G., Hebert M.D. Control of Cajal body number is mediated by the coilin C-terminus. J Cell Sci 2003, 116:303-312.
43. Cioce M., Lamond A.I. Cajal bodies: a long history of discovery. Annu Rev Cell Dev Biol 2005, 21:105-131.
44. Nizami Z., Deryusheva S., Gall J.G. The Cajal body and histone locus body. Cold Spring Harb Perspect Biol 2010, 2:a000653.
45. Hearst S.M., Gilder A.S., Negi S.S., Davis M.D., George E.M., Whittom A.A., et al. Cajal-body formation correlates with differential coilin phosphorylation in primary and transformed cell lines. J Cell Sci 2009, 122:1872-1881.
46. Hebert M.D., Szymczyk P.W., Shpargel K.B., Matera A.G. Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev 2001, 15:2720-2729.
47. Hebert M.D. Phosphorylation and the Cajal body: modification in search of function. Arch Biochem Biophys 2010, 496:69-76.
48. Aihara H., Nakagawa T., Yasui K., Ohta T., Hirose S., Dhomae N., et al. Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. Genes Dev 2004, 18:877-888.
49. Orr H.T. Nuclear ataxias. Cold Spring Harb Perspect Biol 2010, 2:a000786.
50. de Chiara C., Menon R.P., Strom M., Gibson T.J., Pastore A. Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors. PLoS One 2009, 4:e8372.
51. Hubbers C.U., Clemen C.S., Kesper K., Boddrich A., Hofmann A., Kamarainen O., et al. Pathological consequences of VCP mutations on human striated muscle. Brain 2007, 130:381-393.
52. Ishigaki S., Hishikawa N., Niwa J., Iemura S., Natsume T., Hori S., et al. Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem 2004, 279:51376-51385.
53. Koike M., Fukushi J., Ichinohe Y., Higashimae N., Fujishiro M., Sasaki C., et al. Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression. J Biol Chem 2010, 285:21736-21749.
54. Manno A., Noguchi M., Fukushi J., Motohashi Y., Kakizuka A. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Genes Cells 2010, 15:911-922.
55. Banfi S., Servadio A., Chung M.Y., Kwiatkowski T.J., McCall A.E., Duvick L.A., et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 1994, 7:513-520.
56. Wee C.D., Kong L., Sumner C.J. The genetics of spinal muscular atrophies. Curr Opin Neurol 2010, 23:450-458.
57. Wiebe M.S., Nichols R.J., Molitor T.P., Lindgren J.K., Traktman P. Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia. Biol Reprod 2010, 82:182-193.
58. Choi Y.H., Park C.H., Kim W., Ling H., Kang A., Chang M.W., et al. Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells. PLoS One 2010, 5:e15254.
59. Schober C.S., Aydiner F., Booth C.J., Seli E., Reinke V. The kinase VRK1 is required for normal meiotic progression in mammalian oogenesis. Mech Dev 2011, 128:178-190.
60. Walker M.P., Tian L., Matera A.G. Reduced viability, fertility and fecundity in mice lacking the Cajal body marker protein, coilin. PLoS One 2009, 4:e6171.